NFKB1 and COVID-19: Hyper-activation of the nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) pathway has been implicated in the pathogenesis of the severe/critical COVID19 phenotype (Hirano and Murakami, 2020).